NOVARTIS INDIA
Back to Cashflow Statement
|
NOVARTIS INDIA Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-64 Cr | ₹-121 Cr | ₹-30 Cr | ₹-36 Cr | ₹-37 Cr |
What is the latest Cash Flow from Financing Activities ratio of NOVARTIS INDIA ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2025 | ₹-64 Cr |
Mar2024 | ₹-121 Cr |
Mar2023 | ₹-30 Cr |
Mar2022 | ₹-36 Cr |
Mar2021 | ₹-37 Cr |
How is Cash Flow from Financing Activities of NOVARTIS INDIA Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹-64 Cr | Negative | |
Mar2024 | ₹-121 Cr | Negative | |
Mar2023 | ₹-30 Cr | Negative | |
Mar2022 | ₹-36 Cr | Negative | |
Mar2021 | ₹-37 Cr | - |
Compare Cash Flow from Financing Activities of peers of NOVARTIS INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NOVARTIS INDIA | ₹2,180.8 Cr | -1.9% | -6.2% | -23.4% | Stock Analytics | |
ADANI ENTERPRISES | ₹299,112.0 Cr | -4.4% | 9.8% | -19.6% | Stock Analytics | |
REDINGTON | ₹21,795.9 Cr | 3.4% | 16.2% | 57.1% | Stock Analytics | |
LLOYDS ENTERPRISES | ₹9,895.1 Cr | -5% | -13.8% | 41.1% | Stock Analytics | |
MMTC | ₹9,807.0 Cr | -5.2% | 4.1% | -28.1% | Stock Analytics | |
HONASA CONSUMER | ₹9,328.4 Cr | -6.5% | -6.2% | -42% | Stock Analytics |
NOVARTIS INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NOVARTIS INDIA | -1.9% |
-6.2% |
-23.4% |
SENSEX | -0.9% |
0.8% |
-5.7% |
You may also like the below Video Courses